Bartter's syndrome is a disorder characterized by hypokalaemia, hyperreninaemic hyperaldosteronism and juxtaglomerular hyperplasia. 1 Other features are pressor resistance to angiotensin II (ANG II), overproduction of renal prostaglandins and renal tubular dysfunction such as defective sodium and chloride reabsorption, and potassium and magnesium wasting.? Gitelman's syndrome is a variant of Bartter's syndrome presenting in adult life characterized by hypokalaemia and hypomagncsaemia. Patients with classic Banter's syndrome present with symptoms of hypokaIaemia or growth failure, whereas Gitelman's syndrome is usually discovered by chance. We report a case of Gitelman's variant presenting with tonic-clonic seizures associated with hypomagnesaemia.
CASE REPORT
A 23-year-old man presented after two generalized tonic-clonic convulsions. There had been no muscle weakness, myoclonic jerks, tetany, polyuria or polydipsia. He had undergone normal development through childhood and puberty. He denied taking diuretics and purgatives and no surreptitious ingestion of medication was observed during 3 weeks admission under metabolic ward conditions. Clinical examination was normal. His weight was 60 kg and height 167 em. He remained normotensive. Computed tomography of the brain and electro-encephalogram were normal. The serum sodium was 137mmol/L, serum potassium 2 -7 mmol/L, serum magnesium 0-43 mmol/L. Serum calcium, phosphate and creatinine were repeatedly normal. Urine Correspondence; Dr C J Gibbs. 426 calcium/creatinine molar ratio (mean of 4 days collection) was 0·13 and urine magnesium! creatinine molar ratio was 0·25. He was investigated as follows:
Angiotensin II infusion ANG II ('Hypertensin', Ciba Geigy) was infused until a 20 mmHg rise in diastolic blood pressure was achieved. Increments in ANG II were made every 30 min at the following rates: 0-5, 0-75, 1'0, 1'5,2-0,3'0,4-0,5'0,6-0, 8-0 ",g!min.
Plasma samples were taken at 30 min intervals for aldosterone and 60 min intervals for plasma renin activity (PRA).
Effect of high sodium, low sodium and high potassium diet Serum electrolytes, plasma renin activity (PRA) (recumbent and erect), plasma aldosterone (recumbent and erect), urinary electrolytes, and urinary kallikrein were measured on a control diet, a low sodium diet, a high sodium diet, and a high potassium diet on an endocrinology ward under close nursing and dietetic supervision. The composition of the diet is shown in Table I .
Effect of magnesium supplements and indomethacin
Serum and urinary electrolytes, PRA and plasma aldosterone were measured after 8 weeks treatment with indomethacin 25 mg 8 hourly and magnesium glycerophosphate 3 g 6 hourly orally (equivalent to 48 mmol of magnesium daily) on a high potassium diet (128 mmol sodium, 200 mmol potassium, 17 mmol magnesium).
PRA was measured by an in-house assay based on the method of Haber." but controlling for pH. Aldosterone was measured by direct radioimmunoassay." Urinary kallikrein was measured by the method of Amundsen et al., 5 using purified porcine pancreatic kallikrein as the standard. Angiotensin II infusion There was pressor resistance to ANG II infusion with a 20 mmHg rise in diastolic pressure occurring at 8·0 JLg/min (133 ng/kg/min) (normal range = 7·4± 1·3 ng/kg/min)." ANG II infusion resulted in physiological stimulation of aldosterone secretion and suppression of plasma renin activity ( Fig. 1 ).
Low sodium, high sodium, high potassium diet Serum sodium remained normal, whereas serum potassium and magnesium remained low throughout the study. Electrolyte balance is shown in Table I . Urinary sodium was high but there was conservation with a low dietary sodium and natriuresis with a high dietary sodium.
Urinary potassium was high and little conservation occurred on a low potassium intake.
Urinary magnesium was high in relation to serum magnesium concentrations. Conservation occurred with a low magnesium intake and also with a high potassium intake.
PRA results are shown in Fig. 2 . PRA was elevated and was not suppressed by high sodium intake nor influenced by high potassium intake. PRA was stimulated by low sodium intake. There were normal increments in PRA on ambulation (not illustrated). Plasma aldosterone (ambulant) and active urinary kallikrein are shown in Fig. 3 . Plasma aldosterone was raised, but low in relation to the high plasma renin activity. Plasma aldosterone rose physiologically with a low sodium diet and a high potassium diet, and fell with a high sodium diet. There were normal responses to posture with elevation in aldosterone on ambulation compared to recumbent values (not illustrated). Active urinary kallikrein was elevated and rose further following the rise in plasma aldosterone, after a lag period. This young man had hyperreninaemia, kaliuresis and pressor resistance to ANG II which are features typically found in classic Bartter's syndrome.' Whilst he had no symptoms from hypokalaemia, resistant hypomagnesaemia due to a renal magnesium leak most probably caused recurrent fitting.
Although hypomagnesaemia is also a feature of classic Bartter's syndrome.? our patient's late presentation with with hypomagnesaemia and lack of growth delay and polyuria are more typical of Gitelman's variant. An early report of a syndrome in adults characterized by hypomagnesaemia and relatively normal aldosterone levels, Gitelman's syndrome," is now considered to be a well-defined variant of Bartter's syndrome." Gitelman's syndrome is differentiated from classic Bartter's syndrome by some
Effect of indomethacin and magnesium supplements
On indomethacin 25 mg 8 hourly and a high potassium diet the serum potassium rose to 3 . 6 mmol/L and the urinary potassium fell to 76 mmol/day. The serum magnesium remained low at 0·47 mmol/L. Further convulsions occurred in the presence of normal serum calcium and potassium concentrations, suggesting the fits were induced by resistant hypomagnesaemia. Magnesium supplements resulted in an increase in serum magnesium but not into the normal range. The serum magnesium varied between 0·54 and 0·65 mmol/L. Urinary magnesium increased to 10· 4 mmol/day confirming absorption of oral magnesium and reflecting a renal magnesium leak in the face of hypomagnesaemia.
PRA concentrations were suppressed by indomethacin to 6· 9 nmol/L/h (recumbent) and 7· 8 nmol/Llh (ambulant) and plasma aldosterone returned to the normal range.
The convulsions were not controlled until the patient was treated with phenytoin 300 mg daily in addition to magnesium glycerophosphate and indomethacin. Plasma aldosterone may not be as high as expected for the degree of hyperreninaemia in both syndromes because of the low total body potassium. Aldosterone responses to diet and posture were qualitatively normal in our patient implying there was no primary abnormality of the RAA system. Urinary excretion of active tissue kallikrein (AUK) is closely associated with mineralocorticoid activity!' and the high levels of aldosterone would be expected to increase AUK. A high AUK has been found, however, even when aldosterone is normal in Bartter's syndrome," so there may be independent factors operating.
DISCUSSION
The underlying renal prostaglandin abnormality responded to the prostaglandin synthetase inhibitor indomethacin, correcting the hyperreninaemia and renal potassium leak. The renal magnesium leak does not appear to be dependent on this mechanism and may be a primary tubular defect. We can rule out hyperaldosteronism as a cause for excess urinary magnesium in this case because severe magnesium depletion persisted despite normal aldosterone concentrations, but we cannot exclude a magnesium leak due to structural damage to the renal tubular cells" from prolonged hypokalaemia.
Treatment with magnesium supplements proved difficult because the preparations are bulky and need to be taken four times a day, reducing compliance. Many magnesium preparations cause diarrhoea, which could potentially worsen hypokalaemia and therefore we chose magnesium glycerophosphate rather than magnesium hydroxide or magnesium sulphate. This was well tolerated but absorption appeared to be erratic as judged by the variation in the patient's serum magnesium which left him prone to convulsions. Our patient was completely asymptomatic once established on anticonvulsant treatment and so we did not resort to intermittent intravenous infusions of magnesium which have been used successfully in other patients with severe hypomagnesaemia." Chronic hypomagnesaemia in reported cases of Gitelman's syndrome is surprisingly benign, but symptoms described include febrile seizures and tetanic episodes in 75%. 9 This is the first patient with Gitelman's syndrome who has presented with hypomagnesaemic convulsions. Tetany described in other patients may arise from hypomagnesaemia directly or from functional hypoparathyroidism. A third of patients with classic Bartter's syndrome have renal magnesium wasting? and despite the absence of tetany, magnesium depletion frequently contributes to other symptoms in severe cases of Bartter's syndrome such as apathy, anorexia and muscle weakness."
It would be wise to measure serum magnesium in all patients with known Bartter's syndrome and in patients with unexplained hypokalaemia, growth failure, tetany or convulsions. Conversely, all patients with chronic hypomagnesaemia should be investigated for features of Bartter's and Gitelman's syndromes and an attempt should be made to classify them according to their clinical course and urinary calcium excretion. ANG II infusions and study of the RAA and KK systems will not discriminate between the two syndromes.
